Posted inInfectious Diseases news Ophthalmology
Temporal Dynamics of Valacyclovir Prophylaxis in Herpes Zoster Ophthalmicus: Insights from the Zoster Eye Disease Study
This analysis of the ZEDS trial suggests that valacyclovir prophylaxis offers temporally localized protection against recurrent ocular inflammation in herpes zoster ophthalmicus, supporting one-year suppressive therapy despite non-significant primary outcomes.